{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["colon cancer cells and spheroids", "delivery system for cancer targeting", "folic acid", "hydroxyapatite nanocarrier", "in vitro release kinetics", "nanoformulations", "natural products", "pH-sustained release effect", "piperine alkaloid prodrug"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31963155", "DateRevised": {"Year": "2024", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "16"}], "Language": ["eng"], "ELocationID": ["70", "10.3390/pharmaceutics12010070"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "16"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles.", "Abstract": {"AbstractText": ["Targeted drug delivery offers great opportunities for treating cancer. Here, we developed a novel anticancer targeted delivery system for piperine (Pip), an alkaloid prodrug derived from black pepper that exhibits anticancer effects. The tailored delivery system comprises aggregated hydroxyapatite nanoparticles (HAPs) functionalized with phosphonate groups (HAP-Ps). Pip was loaded into HAPs and HAP-Ps at pH 7.2 and 9.3 to obtain nanoformulations. The nanoformulations were characterized using several techniques and the release kinetics and anticancer effects investigated in vitro. The Pip loading capacity was >20%. Prolonged release was observed with kinetics dependent on pH, surface modification, and coating. The nanoformulations fully inhibited monolayer HCT116 colon cancer cells compared to Caco2 colon cancer and MCF7 breast cancer cells after 72 h, whereas free Pip had a weaker effect. The nanoformulations inhibited ~60% in HCT116 spheroids compared to free Pip. The Pip-loaded nanoparticles were also coated with gum Arabic and functionalized with folic acid as a targeting ligand. These functionalized nanoformulations had the lowest cytotoxicity towards normal WI-38 fibroblast cells. These preliminary findings suggest that the targeted delivery system comprising HAP aggregates loaded with Pip, coated with gum Arabic, and functionalized with folic acid are a potentially efficient agent against colon cancer."]}, "AuthorList": [{"Identifier": ["0000-0001-8413-6738"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), P.C. 12622 Dokki, Giza, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, 00-645 Warsaw, Poland."}], "LastName": "Stefanek", "ForeName": "Agata", "Initials": "A"}, {"Identifier": ["0000-0002-4200-0418"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), P.C. 12622 Dokki Giza, Egypt."}], "LastName": "Higazy", "ForeName": "Iman M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, 00-645 Warsaw, Poland."}], "LastName": "Janczewska", "ForeName": "Magdalena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Faculty of Materials Engineering, Warsaw University of Technology, Wo\u0142oska 41, 02-507 Warsaw, Poland."}], "LastName": "Chodara", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": ["0000-0002-6106-5188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Wojnarowicz", "ForeName": "Jacek", "Initials": "J"}, {"Identifier": ["0000-0003-2304-1481"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Faculty of Materials Engineering, Warsaw University of Technology, Wo\u0142oska 41, 02-507 Warsaw, Poland."}], "LastName": "Sza\u0142aj", "ForeName": "Urszula", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Agriculture, Cairo University, P.C. 12613 Giza, Egypt."}], "LastName": "Shahein", "ForeName": "Samar A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Agriculture, Cairo University, P.C. 12613 Giza, Egypt."}], "LastName": "Aboul-Enein", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Agriculture, Cairo University, P.C. 12613 Giza, Egypt."}], "LastName": "Abou-Elella", "ForeName": "Faten", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Gierlotka", "ForeName": "Stanislaw", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, 00-645 Warsaw, Poland."}], "LastName": "Ciach", "ForeName": "Tomasz", "Initials": "T"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "GrantList": [{"GrantID": "internal funding", "Agency": "National Research Centre (NRC, Egypt)", "Country": ""}, {"GrantID": "STRATEGMED3/306888/3/ NCBR/2017, project iTE, Poland", "Agency": "National Center for Research and Development, Poland", "Country": ""}, {"GrantID": "CePT project (reference: POIG.02.02.00-14-024/08)", "Agency": "European Regional Development Fund within the Operational Programme \"Innovative Economy\" for 2007-2013", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferlay J., Colombet M., Soerjomataram I., Dyba T., Randi G., Bettio M., Gavin A., Visser O., Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur. J. Cancer. 2018;103:356\u2013387. doi: 10.1016/j.ejca.2018.07.005.", "ArticleIdList": ["10.1016/j.ejca.2018.07.005", "30100160"]}, {"Citation": "Wirsdorfer F., de Leve S., Jendrossek V. Combining radiotherapy and immunotherapy in lung cancer: Can we expect limitations due to altered normal tissue toxicity? Int. J. Mol. Sci. 2018;20:24. doi: 10.3390/ijms20010024.", "ArticleIdList": ["10.3390/ijms20010024", "PMC6337556", "30577587"]}, {"Citation": "Herskovic A., Martz K., al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., Cooper J., Byhardt R., Davis L., Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 1992;326:1593\u20131598. doi: 10.1056/NEJM199206113262403.", "ArticleIdList": ["10.1056/NEJM199206113262403", "1584260"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Ji H.-F., Li X.-J., Zhang H.-Y. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 2009;10:194\u2013200. doi: 10.1038/embor.2009.12.", "ArticleIdList": ["10.1038/embor.2009.12", "PMC2658564", "19229284"]}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33:1582\u20131614. doi: 10.1016/j.biotechadv.2015.08.001.", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Watkins R., Wu L., Zhang C., Davis R.M., Xu B. Natural product-based nanomedicine: Recent advances and issues. Int. J. Nanomed. 2015;10:6055\u20136074. doi: 10.2147/ijn.s92162.", "ArticleIdList": ["10.2147/ijn.s92162", "PMC4592057", "26451111"]}, {"Citation": "Aljuffali I.A., Fang C.L., Chen C.H., Fang J.Y. Nanomedicine as a strategy for natural compound delivery to prevent and treat cancers. Curr. Pharm. Des. 2016;22:4219\u20134231. doi: 10.2174/1381612822666160620072539.", "ArticleIdList": ["10.2174/1381612822666160620072539", "27323758"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.D.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S., et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Damanhouri Z., Ahmad A. A review on therapeutic potential of Piper nigrum L. (black pepper): The king of spices. Med. Aromat. Plants. 2014;3:161. doi: 10.4172/2167-0412.1000161.", "ArticleIdList": ["10.4172/2167-0412.1000161"]}, {"Citation": "Gorgani L., Mohammadi M., Najafpour G.D., Nikzad M. Piperine\u2014The bioactive compound of black pepper: From isolation to medicinal formulations. Compr. Rev. Food Sci. Food Saf. 2017;16:124\u2013140. doi: 10.1111/1541-4337.12246.", "ArticleIdList": ["10.1111/1541-4337.12246", "33371546"]}, {"Citation": "Koleva I.I., van Beek T.A., Soffers A.E., Dusemund B., Rietjens I.M. Alkaloids in the human food chain\u2014Natural occurrence and possible adverse effects. Mol. Nutr. Food Res. 2012;56:30\u201352. doi: 10.1002/mnfr.201100165.", "ArticleIdList": ["10.1002/mnfr.201100165", "21823220"]}, {"Citation": "Kasibhatta R., Naidu M.U. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: A randomised, crossover, placebo-controlled study. Drugs R D. 2007;8:383\u2013391. doi: 10.2165/00126839-200708060-00006.", "ArticleIdList": ["10.2165/00126839-200708060-00006", "17963429"]}, {"Citation": "Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353\u2013356. doi: 10.1055/s-2006-957450.", "ArticleIdList": ["10.1055/s-2006-957450", "9619120"]}, {"Citation": "Bang J.S., Oh D.H., Choi H.M., Sur B.-J., Lim S.-J., Kim J.Y., Yang H.-I., Yoo M.C., Hahm D.-H., Kim K.S. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res. Ther. 2009;11:R49. doi: 10.1186/ar2662.", "ArticleIdList": ["10.1186/ar2662", "PMC2688199", "19327174"]}, {"Citation": "Yang W., Chen Y.H., Liu H., Qu H.D. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease mouse model. Int. J. Mol. Med. 2015;36:1369\u20131376. doi: 10.3892/ijmm.2015.2356.", "ArticleIdList": ["10.3892/ijmm.2015.2356", "26648012"]}, {"Citation": "Selvendiran K., Singh J.P., Krishnan K.B., Sakthisekaran D. Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia. 2003;74:109\u2013115. doi: 10.1016/S0367-326X(02)00304-0.", "ArticleIdList": ["10.1016/S0367-326X(02)00304-0", "12628402"]}, {"Citation": "Yoo E.S., Choo G.S., Kim S.H., Woo J.S., Kim H.J., Park Y.S., Kim B.S., Kim S.K., Park B.K., Cho S.D., et al. Antitumor and apoptosis-inducing effects of piperine on human melanoma cells. Anticancer Res. 2019;39:1883\u20131892. doi: 10.21873/anticanres.13296.", "ArticleIdList": ["10.21873/anticanres.13296", "30952729"]}, {"Citation": "Si L., Yang R., Lin R., Yang S. Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway. Biosci. Rep. 2018;38 doi: 10.1042/BSR20180503.", "ArticleIdList": ["10.1042/BSR20180503", "PMC6435525", "29717031"]}, {"Citation": "Yaffe P.B., Power Coombs M.R., Doucette C.D., Walsh M., Hoskin D.W. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol. Carcinog. 2015;54:1070\u20131085. doi: 10.1002/mc.22176.", "ArticleIdList": ["10.1002/mc.22176", "24819444"]}, {"Citation": "Selvendiran K., Banu S.M., Sakthisekaran D. Protective effect of piperine on benzo(\u03b1)pyrene-induced lung carcinogenesis in Swiss albino mice. Clinica Chimica Acta. 2004;350:73\u201378. doi: 10.1016/j.cccn.2004.07.004.", "ArticleIdList": ["10.1016/j.cccn.2004.07.004", "15530462"]}, {"Citation": "Samykutty A., Shetty A.V., Dakshinamoorthy G., Bartik M.M., Johnson G.L., Webb B., Zheng G., Chen A., Kalyanasundaram R., Munirathinam G. Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate cancer cells. PLoS ONE. 2013;8:e65889. doi: 10.1371/journal.pone.0065889.", "ArticleIdList": ["10.1371/journal.pone.0065889", "PMC3688824", "23824300"]}, {"Citation": "Do M.T., Kim H.G., Choi J.H., Khanal T., Park B.H., Tran T.P., Jeong T.C., Jeong H.G. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 2013;141:2591\u20132599. doi: 10.1016/j.foodchem.2013.04.125.", "ArticleIdList": ["10.1016/j.foodchem.2013.04.125", "23870999"]}, {"Citation": "Gunasekaran V., Elangovan K., Niranjali Devaraj S. Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem. Toxicol. 2017;105:106\u2013118. doi: 10.1016/j.fct.2017.03.029.", "ArticleIdList": ["10.1016/j.fct.2017.03.029", "28341137"]}, {"Citation": "Anissian D., Ghasemi-Kasman M., Khalili-Fomeshi M., Akbari A., Hashemian M., Kazemi S., Moghadamnia A.A. Piperine-loaded chitosan-STPP nanoparticles reduce neuronal loss and astrocytes activation in chemical kindling model of epilepsy. Int. J. Biol. Macromol. 2018;107:973\u2013983. doi: 10.1016/j.ijbiomac.2017.09.073.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.09.073", "28939512"]}, {"Citation": "Bhalekar M.R., Madgulkar A.R., Desale P.S., Marium G. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis. Drug Dev. Ind. Pharm. 2017;43:1003\u20131010. doi: 10.1080/03639045.2017.1291666.", "ArticleIdList": ["10.1080/03639045.2017.1291666", "28161984"]}, {"Citation": "Katiyar S.S., Muntimadugu E., Rafeeqi T.A., Domb A.J., Khan W. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv. 2016;23:2608\u20132616. doi: 10.3109/10717544.2015.1039667.", "ArticleIdList": ["10.3109/10717544.2015.1039667", "26036652"]}, {"Citation": "Elnaggar Y.S.R., Etman S.M., Abdelmonsif D.A., Abdallah O.Y. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: Optimization, biological efficacy, and potential toxicity. J. Pharm. Sci. 2015;104:3544\u20133556. doi: 10.1002/jps.24557.", "ArticleIdList": ["10.1002/jps.24557", "26147711"]}, {"Citation": "Shao B., Cui C., Ji H., Tang J., Wang Z., Liu H., Qin M., Li X., Wu L. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: In vitro, in vivo and in situ intestinal permeability studies. Drug Deliv. 2015;22:740\u2013747. doi: 10.3109/10717544.2014.898109.", "ArticleIdList": ["10.3109/10717544.2014.898109", "24670090"]}, {"Citation": "AbouAitah K., Swiderska-Sroda A., Farghali A.A., Wojnarowicz J., Stefanek A., Gierlotka S., Opalinska A., Allayeh A.K., Ciach T., Lojkowski W. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget. 2018;9:26466\u201326490. doi: 10.18632/oncotarget.25470.", "ArticleIdList": ["10.18632/oncotarget.25470", "PMC5995188", "29899871"]}, {"Citation": "Shahein S.A., Aboul-Enein A.M., Higazy I.M., Abou-Elella F., Lojkowski W., Ahmed E.R., Mousa S.A., AbouAitah K. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Int. J. Nanomed. 2019;14:5503\u20135526. doi: 10.2147/IJN.S206899.", "ArticleIdList": ["10.2147/IJN.S206899", "PMC6650459", "31410001"]}, {"Citation": "Mart\u00ednez-Carmona M., Gun\u2019ko Y., Vallet-Reg\u00ed M. ZnO nanostructures for drug delivery and theranostic applications. Nanomaterials. 2018;8:268. doi: 10.3390/nano8040268.", "ArticleIdList": ["10.3390/nano8040268", "PMC5923598", "29690644"]}, {"Citation": "Albinali K.E., Zagho M.M., Deng Y., Elzatahry A.A. A perspective on magnetic core-shell carriers for responsive and targeted drug delivery systems. Int. J. Nanomed. 2019;14:1707\u20131723. doi: 10.2147/IJN.S193981.", "ArticleIdList": ["10.2147/IJN.S193981", "PMC6408922", "30880975"]}, {"Citation": "Palazzo B., Iafisco M., Laforgia M., Margiotta N., Natile G., Bianchi C.L., Walsh D., Mann S., Roveri N. Biomimetic hydroxyapatite\u2013drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv. Funct. Mater. 2007;17:2180\u20132188. doi: 10.1002/adfm.200600361.", "ArticleIdList": ["10.1002/adfm.200600361"]}, {"Citation": "Zhu S.H., Huang B.Y., Zhou K.C., Huang S.P., Liu F., Li Y.M., Xue Z.G., Long Z.G. Hydroxyapatite nanoparticles as a novel gene carrier. J. Nanoparticle Res. 2004;6:307\u2013311. doi: 10.1023/B:NANO.0000034721.06473.23.", "ArticleIdList": ["10.1023/B:NANO.0000034721.06473.23"]}, {"Citation": "Li D., Huang X., Wu Y., Li J., Cheng W., He J., Tian H., Huang Y. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug. Biomater. Sci. 2016;4:272\u2013280. doi: 10.1039/C5BM00228A.", "ArticleIdList": ["10.1039/C5BM00228A", "26484364"]}, {"Citation": "Ignjatovi\u0107 N.L., Penov-Ga\u0161i K.M., Wu V.M., Ajdukovi\u0107 J.J., Koji\u0107 V.V., Vasiljevi\u0107-Radovi\u0107 D., Kuzmanovi\u0107 M., Uskokovi\u0107 V., Uskokovi\u0107 D.P. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor. Colloids Surf. B Biointerfaces. 2016;148:629\u2013639. doi: 10.1016/j.colsurfb.2016.09.041.", "ArticleIdList": ["10.1016/j.colsurfb.2016.09.041", "PMC5096963", "27694053"]}, {"Citation": "Xiong H., Du S., Zhang P., Jiang Z., Zhou J., Yao J. Primary tumor and pre-metastatic niches co-targeting \u201cpeptides-lego\u201d hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Biomater. Sci. 2018;6:2591\u20132604. doi: 10.1039/C8BM00706C.", "ArticleIdList": ["10.1039/C8BM00706C", "30187035"]}, {"Citation": "Ignjatovic N.L., Sakac M., Kuzminac I., Kojic V., Markovic S., Vasiljevic-Radovic D., Wu V.M., Uskokovic V., Uskokovic D.P. Chitosan oligosaccharide lactate coated hydroxyapatite nanoparticles as a vehicle for the delivery of steroid drugs and the targeting of breast cancer cells. J. Mater. Chem. B. 2018;6:6957\u20136968. doi: 10.1039/C8TB01995A.", "ArticleIdList": ["10.1039/C8TB01995A", "PMC6436965", "30931125"]}, {"Citation": "Higuchi J., Fortunato G., Wozniak B., Chodara A., Domaschke S., Meczynska-Wielgosz S., Kruszewski M., Dommann A., Lojkowski W. Polymer membranes sonocoated and electrosprayed with nano-hydroxyapatite for periodontal tissues regeneration. Nanomaterials. 2019;9:1625. doi: 10.3390/nano9111625.", "ArticleIdList": ["10.3390/nano9111625", "PMC6915502", "31731775"]}, {"Citation": "Rogowska-Tylman J., Locs J., Salma I., Wo\u017aniak B., Pilmane M., Zalite V., Wojnarowicz J., K\u0119dzierska-Sar A., Chudoba T., Szl\u0105zak K., et al. In vivo and in vitro study of a novel nanohydroxyapatite sonocoated scaffolds for enhanced bone regeneration. Mater. Sci. Eng. C. 2019;99:669\u2013684. doi: 10.1016/j.msec.2019.01.084.", "ArticleIdList": ["10.1016/j.msec.2019.01.084", "30889740"]}, {"Citation": "Ku\u015bnieruk S., Wojnarowicz J., Chodara A., Chudoba T., Gierlotka S., Lojkowski W. Influence of hydrothermal synthesis parameters on the properties of hydroxyapatite nanoparticles. Beilstein J. Nanotechnol. 2016;7:1586\u20131601. doi: 10.3762/bjnano.7.153.", "ArticleIdList": ["10.3762/bjnano.7.153", "PMC5238695", "28144510"]}, {"Citation": "Ammar H.O., Ghorab M.M., Mahmoud A.A., Higazy I.M. Lamotrigine loaded poly-\u03b5-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2018;115:77\u201387. doi: 10.1016/j.ejps.2018.01.028.", "ArticleIdList": ["10.1016/j.ejps.2018.01.028", "29341900"]}, {"Citation": "Assaad H.I., Zhou L., Carroll R.J., Wu G. Rapid publication-ready MS-Word tables for one-way ANOVA. SpringerPlus. 2014;3:474. doi: 10.1186/2193-1801-3-474.", "ArticleIdList": ["10.1186/2193-1801-3-474", "PMC4153873", "25191639"]}, {"Citation": "Padmanabhan V.P., Kulandaivelu R., Santhana Panneer D., Vivekananthan S., Sagadevan S., Anita Lett J. Microwave synthesis of hydroxyapatite encumbered with ascorbic acid intended for drug leaching studies. Mater. Res. Innov. 2019:1\u20138. doi: 10.1080/14328917.2019.1624940.", "ArticleIdList": ["10.1080/14328917.2019.1624940"]}, {"Citation": "Shingate P., Dongre P., Kannur D. New method development for extraction and isolation of piperine from black pepper. Int. J. Pharm. Sci. Res. 2013;4:3165\u20133170."}, {"Citation": "Dahiya S., Rani R., Dhingra D., Kumar S., Dilbaghi N. Conjugation of epigallocatechin gallate and piperine into a zein nanocarrier: Implication on antioxidant and anticancer potential. Adv. Nat. Sci. Nanosci. Nanotechnol. 2018;9:035011. doi: 10.1088/2043-6254/aad5c1.", "ArticleIdList": ["10.1088/2043-6254/aad5c1"]}, {"Citation": "Ibekwe C.A., Oyatogun G.M., Esan T.A., Oluwasegun K.M. Synthesis and characterization of chitosan/gum Arabic nanoparticles for bone regeneration. Am. J. Mater. Sci. Eng. 2017;5:28\u201336. doi: 10.12691/ajmse-5-1-4.", "ArticleIdList": ["10.12691/ajmse-5-1-4"]}, {"Citation": "Pal K., Roy S., Parida P.K., Dutta A., Bardhan S., Das S., Jana K., Karmakar P. Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and in vivo model. Mater. Sci. Eng. C Mater. Biol. Appl. 2019;95:204\u2013216. doi: 10.1016/j.msec.2018.10.071.", "ArticleIdList": ["10.1016/j.msec.2018.10.071", "30573243"]}, {"Citation": "Tiwari A., Singh A., Debnath A., Kaul A., Garg N., Mathur R., Singh A., Randhawa J.K. Multifunctional magneto-fluorescent nanocarriers for dual mode imaging and targeted drug delivery. ACS Appl. Nano Mater. 2019;2:3060\u20133072. doi: 10.1021/acsanm.9b00421.", "ArticleIdList": ["10.1021/acsanm.9b00421"]}, {"Citation": "Li J., Shen S., Kong F., Jiang T., Tang C., Yin C. Effects of pore size on in vitro and in vivo anticancer efficacies of mesoporous silica nanoparticles. RSC Adv. 2018;8:24633\u201324640. doi: 10.1039/C8RA03914C.", "ArticleIdList": ["10.1039/C8RA03914C", "PMC9082023", "35539161"]}, {"Citation": "Bavnh\u00f8j C.G., Knopp M.M., Madsen C.M., L\u00f6bmann K. The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity. Int. J. Pharm. X. 2019;1:100008. doi: 10.1016/j.ijpx.2019.100008.", "ArticleIdList": ["10.1016/j.ijpx.2019.100008", "PMC6733371", "31517273"]}, {"Citation": "Manayi A., Nabavi S.M., Setzer W.N., Jafari S. Piperine as a potential anti-cancer agent: A review on preclinical studies. Curr. Med. Chem. 2018;25:4918\u20134928. doi: 10.2174/0929867324666170523120656.", "ArticleIdList": ["10.2174/0929867324666170523120656", "28545378"]}, {"Citation": "Lai L.H., Fu Q.H., Liu Y., Jiang K., Guo Q.M., Chen Q.Y., Yan B., Wang Q.Q., Shen J.G. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacologica Sinica. 2012;33:523\u2013530. doi: 10.1038/aps.2011.209.", "ArticleIdList": ["10.1038/aps.2011.209", "PMC4003369", "22388073"]}, {"Citation": "Rather R.A., Bhagat M. Cancer chemoprevention and piperine: Molecular mechanisms and therapeutic opportunities. Front. Cell Dev. Biol. 2018;6:10. doi: 10.3389/fcell.2018.00010.", "ArticleIdList": ["10.3389/fcell.2018.00010", "PMC5818432", "29497610"]}, {"Citation": "Syed S.B., Arya H., Fu I.H., Yeh T.K., Periyasamy L., Hsieh H.P., Coumar M.S. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer. Sci. Rep. 2017;7:7972. doi: 10.1038/s41598-017-08062-2.", "ArticleIdList": ["10.1038/s41598-017-08062-2", "PMC5554262", "28801675"]}, {"Citation": "Wu F., Lin D.D.W., Chang J.H., Fischbach C., Estroff L.A., Gourdon D. Effect of the materials properties of hydroxyapatite nanoparticles on fibronectin deposition and conformation. Cryst. Growth Des. 2015;15:2452\u20132460. doi: 10.1021/acs.cgd.5b00231.", "ArticleIdList": ["10.1021/acs.cgd.5b00231", "PMC4527546", "26257585"]}, {"Citation": "\u015al\u00f3sarczyk A., Szymura-Oleksiak J., Mycek B. The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants. Biomaterials. 2000;21:1215\u20131221. doi: 10.1016/S0142-9612(99)00269-0.", "ArticleIdList": ["10.1016/S0142-9612(99)00269-0", "10811303"]}, {"Citation": "Oberbek P., Bolek T., Chlanda A., Hirano S., Kusnieruk S., Rogowska-Tylman J., Nechyporenko G., Zinchenko V., Swieszkowski W., Puzyn T. Characterization and influence of hydroxyapatite nanopowders on living cells. Beilstein J. Nanotechnol. 2018;9:3079\u20133094. doi: 10.3762/bjnano.9.286.", "ArticleIdList": ["10.3762/bjnano.9.286", "PMC6317412", "30643706"]}, {"Citation": "Jauregui-Osoro M., Williamson P.A., Glaria A., Sunassee K., Charoenphun P., Green M.A., Mullen G.E.D., Blower P.J. Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging. Dalton Trans. 2011;40:6226\u20136237. doi: 10.1039/c0dt01618g.", "ArticleIdList": ["10.1039/c0dt01618g", "PMC3929900", "21394352"]}, {"Citation": "Lobaz V., Konefa\u0142 R., P\u00e1nek J., Vlk M., Kozempel J., Pet\u0159\u00edk M., Novy Z., Gursk\u00e1 S., Znojek P., \u0160t\u011bp\u00e1nek P., et al. In situ in vivo radiolabeling of polymer-coated hydroxyapatite nanoparticles to track their biodistribution in mice. Colloids Surf. B Biointerfaces. 2019;179:143\u2013152. doi: 10.1016/j.colsurfb.2019.03.057.", "ArticleIdList": ["10.1016/j.colsurfb.2019.03.057", "30954015"]}, {"Citation": "Sayed E., Karavasili C., Ruparelia K., Haj-Ahmad R., Charalambopoulou G., Steriotis T., Giasafaki D., Cox P., Singh N., Giassafaki L.-P.N., et al. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: In vitro and ex vivo evaluation. J. Control. Release. 2018;278:142\u2013155. doi: 10.1016/j.jconrel.2018.03.031.", "ArticleIdList": ["10.1016/j.jconrel.2018.03.031", "29605567"]}, {"Citation": "Han C., Huang H., Dong Y., Sui X., Jian B., Zhu W. A comparative study of the use of mesoporous carbon and mesoporous silica as drug carriers for oral delivery of the water-insoluble drug carvedilol. Molecules. 2019;24:1770. doi: 10.3390/molecules24091770.", "ArticleIdList": ["10.3390/molecules24091770", "PMC6539599", "31067732"]}, {"Citation": "Le T.T., Elzhry Elyafi A.K., Mohammed A.R., Al-Khattawi A. Delivery of poorly soluble drugs via mesoporous silica: Impact of drug overloading on release and thermal profiles. Pharmaceutics. 2019;11:269. doi: 10.3390/pharmaceutics11060269.", "ArticleIdList": ["10.3390/pharmaceutics11060269", "PMC6630575", "31185610"]}, {"Citation": "Shen S., Wu Y., Liu Y., Wu D. High drug-loading nanomedicines: Progress, current status, and prospects. Int. J. Nanomed. 2017;12:4085\u20134109. doi: 10.2147/IJN.S132780.", "ArticleIdList": ["10.2147/IJN.S132780", "PMC5459982", "28615938"]}, {"Citation": "Ding Y., Wang C., Wang Y., Xu Y., Zhao J., Gao M., Ding Y., Peng J., Li L. Development and evaluation of a novel drug delivery: Soluplus\u00ae/TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Dev. Ind. Pharm. 2018;44:1409\u20131416. doi: 10.1080/03639045.2018.1472277.", "ArticleIdList": ["10.1080/03639045.2018.1472277", "29718714"]}, {"Citation": "Huang X.S., Lin X.Z., Guo M.T., Zou Y. Characteristics of piperine solubility in multiple solvent. Adv. Mat. Res. 2011;236\u2013238:2495\u20132498. doi: 10.4028/www.scientific.net/AMR.236-238.2495.", "ArticleIdList": ["10.4028/www.scientific.net/AMR.236-238.2495"]}, {"Citation": "Barahuie F., Dorniani D., Saifullah B., Gothai S., Hussein M.Z., Pandurangan A.K., Arulselvan P., Norhaizan M.E. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system. Int. J. Nanomed. 2017;12:2361\u20132372. doi: 10.2147/IJN.S126245.", "ArticleIdList": ["10.2147/IJN.S126245", "PMC5376211", "28392693"]}, {"Citation": "Laha A., Yadav S., Majumdar S., Sharma C.S. In-vitro release study of hydrophobic drug using electrospun cross-linked gelatin nanofibers. Biochem. Eng. J. 2016;105:481\u2013488. doi: 10.1016/j.bej.2015.11.001.", "ArticleIdList": ["10.1016/j.bej.2015.11.001"]}, {"Citation": "Selvakumar M., Kumar P.S., Das B., Dhara S., Chattopadhyay S. Structurally tuned antimicrobial mesoporous hydroxyapatite nanorods by cyclic oligosaccharides regulation to release a drug for osteomyelitis. Cryst. Growth Des. 2017;17:433\u2013445. doi: 10.1021/acs.cgd.6b01190.", "ArticleIdList": ["10.1021/acs.cgd.6b01190"]}, {"Citation": "Poletto F.S., J\u00e4ger E., R\u00e9 M.I., Guterres S.S., Pohlmann A.R. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs. Int. J. Pharm. 2007;345:70\u201380. doi: 10.1016/j.ijpharm.2007.05.040.", "ArticleIdList": ["10.1016/j.ijpharm.2007.05.040", "17604922"]}, {"Citation": "Peppas N.A., Narasimhan B. Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems. J. Control. Release Off. J. Control. Release Soc. 2014;190:75\u201381. doi: 10.1016/j.jconrel.2014.06.041.", "ArticleIdList": ["10.1016/j.jconrel.2014.06.041", "24998939"]}, {"Citation": "Zhang L., Yu F., Cole A.J., Chertok B., David A.E., Wang J., Yang V.C. Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J. 2009;11:693\u2013699. doi: 10.1208/s12248-009-9151-y.", "ArticleIdList": ["10.1208/s12248-009-9151-y", "PMC2782085", "19842043"]}, {"Citation": "Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975;27:48\u201349. doi: 10.1111/j.2042-7158.1975.tb09378.x.", "ArticleIdList": ["10.1111/j.2042-7158.1975.tb09378.x", "235616"]}, {"Citation": "Rinaki E., Dokoumetzidis A., Macheras P. The mean dissolution time depends on the dose/solubility ratio. Pharm. Res. 2003;20:406\u2013408. doi: 10.1023/A:1022652004114.", "ArticleIdList": ["10.1023/A:1022652004114", "12669960"]}, {"Citation": "Hornung A., Poettler M., Friedrich R.P., Zaloga J., Unterweger H., Lyer S., Nowak J., Odenbach S., Alexiou C., Janko C. Treatment efficiency of free and nanoparticle-loaded mitoxantrone for magnetic drug targeting in multicellular tumor spheroids. Molecules. 2015;20:18016\u201318030. doi: 10.3390/molecules201018016.", "ArticleIdList": ["10.3390/molecules201018016", "PMC6332068", "26437393"]}, {"Citation": "Pereira P.M.R., Berisha N., Bhupathiraju N.V.S.D.K., Fernandes R., Tom\u00e9 J.P.C., Drain C.M. Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers. PLoS ONE. 2017;12:e0177737. doi: 10.1371/journal.pone.0177737.", "ArticleIdList": ["10.1371/journal.pone.0177737", "PMC5435229", "28545086"]}, {"Citation": "Nunes A.S., Barros A.S., Costa E.C., Moreira A.F., Correia I.J. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol. Bioeng. 2019;116:206\u2013226. doi: 10.1002/bit.26845.", "ArticleIdList": ["10.1002/bit.26845", "30367820"]}, {"Citation": "Yang S.-J., Lin F.-H., Tsai K.-C., Wei M.-F., Tsai H.-M., Wong J.-M., Shieh M.-J. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem. 2010;21:679\u2013689. doi: 10.1021/bc9004798.", "ArticleIdList": ["10.1021/bc9004798", "20222677"]}, {"Citation": "Soe Z.C., Poudel B.K., Nguyen H.T., Thapa R.K., Ou W., Gautam M., Poudel K., Jin S.G., Jeong J.-H., Ku S.K., et al. Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells. Asian J. Pharm. Sci. 2019;14:40\u201351. doi: 10.1016/j.ajps.2018.09.004.", "ArticleIdList": ["10.1016/j.ajps.2018.09.004", "PMC7032194", "32104437"]}, {"Citation": "Virgone-Carlotta A., Lemasson M., Mertani H.C., Diaz J.-J., Monnier S., Dehoux T., Delano\u00eb-Ayari H., Rivi\u00e8re C., Rieu J.-P. In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil. PLoS ONE. 2017;12:e0188100. doi: 10.1371/journal.pone.0188100.", "ArticleIdList": ["10.1371/journal.pone.0188100", "PMC5687732", "29141026"]}, {"Citation": "Ding J., Chen J., Gao L., Jiang Z., Zhang Y., Li M., Xiao Q., Lee S.S., Chen X. Engineered nanomedicines with enhanced tumor penetration. Nano Today. 2019;29:100800. doi: 10.1016/j.nantod.2019.100800.", "ArticleIdList": ["10.1016/j.nantod.2019.100800"]}, {"Citation": "Ding J., Feng X., Jiang Z., Xu W., Guo H., Zhuang X., Chen X. Polymer-mediated penetration-independent cancer therapy. Biomacromolecules. 2019;20:4258\u20134271. doi: 10.1021/acs.biomac.9b01263.", "ArticleIdList": ["10.1021/acs.biomac.9b01263", "31668061"]}, {"Citation": "Zhang Y., Cai L., Li D., Lao Y.-H., Liu D., Li M., Ding J., Chen X. Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res. 2018;11:4806\u20134822. doi: 10.1007/s12274-018-2066-0.", "ArticleIdList": ["10.1007/s12274-018-2066-0"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "30"}, {"Year": "2019", "Month": "12", "Day": "31"}, {"Year": "2020", "Month": "1", "Day": "8"}, {"Year": "2020", "Month": "1", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31963155", "PMC7022489", "10.3390/pharmaceutics12010070", "pharmaceutics12010070"]}}]}